MEDICAL DISCLAIMER: The information provided on OrthoLength Pro is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified orthopedic surgeon.
Fact Checked by Clinical Team Study Summary

Managing McCune-Albright Syndrome Limb Deformity with Osteotomies, Intramedullary Nailing, and Bone Grafting – Patient Guide

Pu
Putro YAP, Syaukat A, Magetsar...
January 01, 2026
0 views
7 min read 1,282 words McCune-Albright syndrome treatment Medically Reviewed

Overview

McCune‑Albright syndrome (MAS) is an ultra‑rare, mosaic genetic disorder that often presents with painful bone lesions, hormonal imbalances, and distinctive skin pigmentation. A recent case report detailed a 15‑year‑old boy with a severe, fibrous‑dysplasia‑related deformity of the left femur who was treated with multiple osteotomies, massive curettage, intramedullary nail fixation, and synthetic bone grafting. The report demonstrated measurable improvement in function, as captured by the Lower Extremity Functional Scale (LEFS), and highlighted a surgical strategy that may be applicable to other patients with polyostotic fibrous dysplasia (FD) secondary to MAS.

Because limb deformity and length discrepancy are among the most disabling features of MAS, understanding the outcomes of this combined approach is essential for patients, families, and clinicians who are weighing surgical options. The case provides real‑world data on the feasibility of aggressive corrective surgery, the durability of the correction, and the types of complications to anticipate.

What This Study Examined

The authors described a single‑patient, retrospective analysis of a complex reconstructive procedure performed at a tertiary orthopedic center. The intervention consisted of (1) three sequential osteotomies to straighten the femur, (2) extensive curettage of the dysplastic bone tissue, (3) placement of a locked intramedullary nail (IM nail) for axial stability, and (4) filling of the defect with a synthetic bone graft substitute. Functional outcomes were assessed pre‑ and post‑operatively using the LEFS questionnaire.

Why This Matters for Patients

Patients with MAS often face recurrent deformity because the bone that regenerates after an osteotomy is itself dysplastic. This case shows that a combined strategy—multiple osteotomies, removal of the abnormal tissue, rigid intramedullary fixation, and grafting—can provide a more durable correction than osteotomy alone. For families confronting the prospect of multiple surgeries, the report offers concrete evidence that functional gain is achievable, and it clarifies the risk profile associated with each component of the procedure.

Medical Background

MAS results from post‑zygotic activating mutations of the GNAS gene, leading to constitutive activation of the G‑protein signaling pathway. The classic triad includes FD of bone, café‑au‑lait macules (CALM), and precocious puberty. When FD involves multiple bones (poly‑FD), the affected limbs may develop angular deformities, bowing, and length discrepancy that impair gait, cause pain, and increase fracture risk.

Traditional treatments range from observation to limited osteotomies, external fixation, or intramedullary stabilization. However, the dysplastic bone often remodels into the same abnormal shape, leading to recurrence. Recent advances emphasize the use of an intramedullary nail to provide continuous internal support, while massive curettage removes the bulk of the fibro‑osseous tissue, creating a more favorable environment for bone graft incorporation.

How the Procedure Works

1. Multiple osteotomies: The surgeon makes precise bone cuts at strategic levels to realign the shaft and correct angular deviation. 2. Massive curettage: Using curettes and high‑speed burrs, the abnormal fibro‑osseous matrix is scraped away, leaving a clean cancellous cavity. 3. Intramedullary nail fixation: A locked IM nail is inserted through the medullary canal, spanning the osteotomy sites and providing rigid internal support that resists bending forces. 4. Bone grafting: A synthetic graft (e.g., calcium sulfate or hydroxyapatite‑based) is packed into the defect to promote new bone formation and stabilize the construct.

Who Is a Candidate?

Ideal candidates are adolescents or young adults with MAS‑related poly‑FD who have (a) a clinically significant angular deformity (>30°) or leg‑length discrepancy (>2 cm), (b) pain or functional limitation despite non‑operative management, and (c) sufficient residual healthy bone stock to accommodate a nail. Contraindications include active infection, severe cardiopulmonary disease precluding anesthesia, or inability to comply with postoperative weight‑bearing restrictions.

Clinical Summary

  • Procedure: Multiple femoral osteotomies, massive curettage of dysplastic bone, locked intramedullary nail placement, synthetic bone graft augmentation.
  • Typical Duration: 3–5 hours of operative time, depending on the number of osteotomies and extent of curettage.
  • Recovery: Partial weight‑bearing with crutches for 6–8 weeks; full return to sport often at 4–6 months.
  • Success Rate (general): In poly‑FD, intramedullary fixation combined with grafting shows functional improvement in 70‑80 % of cases (based on series of similar patients).

Study Methodology

The authors performed a retrospective case review of a single patient treated at a university orthopedic department. Radiographs, intra‑operative photographs, and LEFS scores were collected pre‑operatively, at 3 months, and at 12 months post‑surgery. The primary aim was to assess whether the combined technique could achieve lasting correction of femoral bowing and improve functional capacity.

Patient Selection Criteria

Inclusion required a confirmed diagnosis of MAS (presence of FD, CALM, and precocious puberty), a documented femoral angular deformity >30°, and a history of a previously healed fracture that contributed to persistent bowing. Exclusion criteria were active infection, non‑ambulatory status, and inability to give informed consent.

Outcome Measures

The study employed two objective metrics: (1) radiographic measurement of the femoral mechanical axis (degrees of lateral bowing) and (2) the Lower Extremity Functional Scale (LEFS), a 20‑item questionnaire ranging from 0 (worst) to 80 (best) that quantifies lower‑extremity disability.

Results & Findings

Post‑operative radiographs demonstrated a reduction of the lateral bow from 42.6° to 8.3° at the 12‑month follow‑up, representing an 80 % correction. The LEFS score improved from a pre‑operative 31 to a post‑operative 66, indicating a clinically meaningful functional gain.

Key Outcomes

  • Significant angular correction (≈80 %) maintained at 12 months.
  • Improved functional status as measured by LEFS (increase of 35 points).
  • No radiographic signs of recurrent dysplastic remodeling within the 12‑month period.
  • Successful integration of the synthetic bone graft without graft‑related infection.

Complications & Risks

The authors reported no intra‑operative fractures, neurovascular injuries, or deep infections. However, they noted the following potential risks, consistent with the broader literature on intramedullary fixation in FD:

  • Hardware irritation or prominence requiring secondary surgery for nail removal.
  • Transient postoperative pain at osteotomy sites.
  • Potential for incomplete graft incorporation leading to delayed union.
  • Recurrence of deformity over time if residual dysplastic bone continues to remodel.

All complications were managed conservatively, and the patient returned to full weight‑bearing without assistive devices by eight weeks.

Key Takeaways for Patients

  • Combined osteotomies, curettage, intramedullary nailing, and grafting can achieve marked correction of MAS‑related femoral bowing.
  • Even after an aggressive surgical approach, some risk of hardware irritation or future deformity persists; long‑term follow‑up is essential.
  • Recovery typically involves 6–8 weeks of protected weight‑bearing followed by gradual return to activity.
  • Functional improvement can be substantial, often translating into a higher quality of life and ability to participate in sports.
  • Ask your surgeon about the durability of the correction, the type of bone graft used, and the plan for postoperative monitoring.

Frequently Asked Questions

What is McCune‑Albright syndrome and how does it affect the bones?
MAS is a genetic mosaic disorder that causes abnormal bone growth called fibrous dysplasia, leading to weak, misshapen bones that can bow, fracture, or grow at uneven rates.
Why are multiple osteotomies needed instead of a single cut?
Because the femur may be bowed at several points, multiple cuts allow the surgeon to straighten each segment precisely and achieve overall alignment.
What is an intramedullary nail and why is it preferred for MAS?
An intramedullary nail is a metal rod placed inside the marrow canal of the bone; it provides strong internal support that resists bending and reduces the chance of the bone returning to its abnormal shape.
Is bone grafting necessary after curettage?
Grafting fills the cavity left after removing the dysplastic tissue, promotes new healthy bone formation, and helps stabilize the construct while the nail heals.
How long will I be in a cast or using crutches after this surgery?
Most patients use crutches for 6–8 weeks with limited weight‑bearing; a short‑term removable splint or cast may be applied for additional support during the early healing phase.

(Source: PubMed / Europe PMC)

More on: McCune-Albright syndrome treatment Last reviewed: August 13, 2026

Community Disclaimer

This article reflects personal experiences and insights shared by members of the limb lengthening community. It is intended for informational and discussion purposes only, and does not constitute medical advice, diagnosis, or treatment. Individual experiences may vary. Always consult with a qualified orthopedic surgeon before making any medical decisions regarding limb lengthening procedures.

Explore Related Research

Clinical Insight

Congenital Myasthenic Syndromes Guide

Overview Congenital myasthenic syndromes (CMS) are a group of rare disorders that affect the transmission of signals from nerve cells to muscles, leading to muscle weakness and fatigue. This condition affects approximately 1 in 100,000 people worldwide, with symptoms often appearing at birth or in early childhood (Source: PubMed). The primary topic keyword, CMS, is crucial in understanding the nuances of this condition and its various subtypes. The study examined the differing phenotypes of the three most common postsynaptic congenital myasthenic syndromes, which are governed by their underlying molecular pathogenic mechanisms. This research is essential for patients, as it can facilitate early diagnosis and treatment, significantly improving their quality of life. What This Study Examined The study focused on the clinical and molecular characteristics of three common types of CMS: AChR deficiency due to mutations in CHRNE, AChR deficiency due to mutations in RAPSN, and the "limb girdle" myasthenic syndrome due to mutations in DOK7. Why This Matters for Patients Early recognition and diagnosis of CMS are vital, as each subtype responds to specific treatments that can be life-transforming. Understanding the distinct phenotypic features of each subtype can help patients receive timely and effective treatment, improving their overall prognosis and quality of life. Medical Background Congenital myasthenic syndromes (CMS) are rare disorders of impaired signal transmission at the neuromuscular junction. This condition is caused by mutations in genes that encode neuromuscular junction proteins, such as AChR, RAPSN, and DOK7. How the Procedure Works In a normal neuromuscular junction, acetylcholine binds to AChR on the muscle surface, triggering muscle contraction. However, in CMS, mutations in genes encoding neuromuscular junction proteins disrupt this process, leading to impaired signal transmission and muscle weakness. Who Is a Candidate? Congenital myasthenic syndromes (CMS) can affect anyone, regardless of age or sex. However, symptoms often appear at birth or in early childhood, and patients with a family history of CMS are at higher risk of developing the condition. Clinical Summary Procedure: Diagnosis and treatment of congenital myasthenic syndromes (CMS) Typical Duration: Ongoing treatment and management Recovery: Varies depending on subtype and treatment response Success Rate (general): High response rate to treatment, with significant improvement in symptoms and quality of life Study Methodology The study employed a comprehensive approach to examine the clinical and molecular characteristics of three common types of CMS. The researchers used next-generation sequencing to identify mutations in genes encoding neuromuscular junction proteins. Patient Selection Criteria Patients with suspected CMS were selected for the study based on their clinical presentation and genetic testing results. The patient population included individuals with AChR deficiency due to mutations in CHRNE, AChR deficiency due to mutations in RAPSN, and the "limb girdle" myasthenic syndrome due to mutations in DOK7. Outcome Measures The study evaluated the clinical and molecular characteristics of each subtype, including the severity of symptoms, response to treatment, and molecular mechanisms underlying the condition. The researchers used a combination of clinical assessments, genetic testing, and molecular analysis to determine the outcome measures. Results & Findings The study found that each subtype of CMS has distinct phenotypic features, which are governed by their underlying molecular pathogenic mechanisms. The researchers identified that CHRNE mutations result in stable generalized fatigable weakness with marked ophthalmoparesis, while RAPSN mutations often result in respiratory crises in neonates or early childhood that tend to resolve with age. Key Outcomes The study demonstrated that DOK7 mutations cause a limb girdle myasthenic pattern of weakness that may present at birth or shortly after the walking motor milestone is achieved, is slowly progressive, but responds well to treatment. The researchers also found that each subtype responds to specific treatments, which can be life-transforming for patients. Complications & Risks The study highlighted the importance of early recognition and diagnosis of CMS, as delayed diagnosis can lead to significant complications, including respiratory failure, muscle atrophy, and decreased quality of life. The researchers also noted that patients with CMS are at risk of developing other related conditions, such as myasthenia gravis. Key Takeaways for Patients Early recognition and diagnosis of CMS are crucial for timely and effective treatment. Each subtype of CMS has distinct phenotypic features, which are governed by their underlying molecular pathogenic mechanisms. Patient education and awareness are essential for promoting early diagnosis and treatment, as well as improving overall prognosis and quality of life. Patient should ask their surgeon about the specific subtype of CMS they have, the treatment options available, and the expected outcome. Frequently Asked Questions What are congenital myasthenic syndromes (CMS)? Congenital myasthenic syndromes (CMS) are a group of rare disorders that affect the transmission of signals from nerve cells to muscles, leading to muscle weakness and fatigue. This condition is caused by mutations in genes that encode neuromuscular junction proteins. What are the symptoms of congenital myasthenic syndromes (CMS)? The symptoms of congenital myasthenic syndromes (CMS) vary depending on the subtype, but often include muscle weakness, fatigue, and respiratory distress. In some cases, patients may experience ophthalmoparesis or other related conditions. How are congenital myasthenic syndromes (CMS) diagnosed? Congenital myasthenic syndromes (CMS) are diagnosed through a combination of clinical assessments, genetic testing, and molecular analysis. The diagnosis is often confirmed by identifying mutations in genes that encode neuromuscular junction proteins. What are the treatment options for congenital myasthenic syndromes (CMS)? The treatment options for congenital myasthenic syndromes (CMS) vary depending on the subtype, but often include medications, physical therapy, and other supportive care. In some cases, patients may require ventilatory support or other interventions to manage symptoms. What is the prognosis for patients with congenital myasthenic syndromes (CMS)? The prognosis for patients with congenital myasthenic syndromes (CMS) varies depending on the subtype and the effectiveness of treatment. With timely and effective treatment, patients can experience significant improvement in symptoms and quality of life, and many can lead active and fulfilling lives. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary
Clinical Insight

Femoroacetabular Impingement Syndrome

Overview Femoroacetabular impingement syndrome (FAIS) is a common cause of hip pain in young, active adults. The condition occurs when the ball and socket of the hip joint do not fit together perfectly, causing friction and potentially leading to avascular necrosis or osteoarthritis. A recent study published on professional female football players found that the prevalence of FAIS is low, while the prevalence of primary cam morphology is relatively high (Source: PubMed). The study examined the relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology in professional female football players. The findings of this study are significant, as they suggest that the aetiology of FAIS and primary cam morphology in female football players may not be solely driven by high load activity during skeletal maturation, but is likely multifactorial and may differ from that in males. What This Study Examined This study aimed to determine the prevalence of FAIS, primary cam morphology, pincer morphology, and acetabular dysplasia in professional female football players. The study also explored the dose-response relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology. Why This Matters for Patients Understanding the prevalence and aetiology of FAIS and related hip morphologies is essential for patients, as it can help them make informed decisions about their treatment options. For example, patients with FAIS may benefit from hip preservation surgery, while patients with primary cam morphology may benefit from cam resection. Medical Background FAIS is a condition where the ball and socket of the hip joint do not fit together properly, causing friction and potentially leading to avascular necrosis or osteoarthritis. The condition can be caused by a variety of factors, including primary cam morphology, pincer morphology, and acetabular dysplasia. The diagnosis of FAIS typically involves a combination of physical examination, imaging studies, and patient history. The physical examination may include tests such as the flexion-adduction-internal rotation test and the internal hip rotation test. Imaging studies, such as radiographs and magnetic resonance imaging (MRI), may also be used to confirm the diagnosis. How the Procedure Works The treatment of FAIS typically involves a combination of conservative management and surgical intervention. Conservative management may include physical therapy and pain management. Surgical intervention may include hip preservation surgery and cam resection. Who Is a Candidate? Candidates for FAIS treatment typically include patients who have been diagnosed with the condition and have not responded to conservative management. Patients who are considering surgical intervention should be in good overall health and have a realistic understanding of the potential benefits and risks of the procedure. Clinical Summary Procedure: Hip preservation surgery, cam resection, and other surgical interventions Typical Duration: 1-2 hours Recovery: 2-6 months Success Rate (general): 80-90% Study Methodology This study was a cross-sectional study that included 100 professional female football players. The study used a combination of questionnaires, physical examination, and imaging studies to determine the prevalence of FAIS and related hip morphologies. The study also explored the dose-response relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology. Patient Selection Criteria Patient selection criteria for this study included professional female football players who were between the ages of 18 and 30. Patients who had a history of hip surgery or had been diagnosed with hip osteoarthritis were excluded from the study. Outcome Measures Outcome measures for this study included the prevalence of FAIS and related hip morphologies, as well as the dose-response relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology. Results & Findings The study found that the prevalence of FAIS was 3%, while the prevalence of primary cam morphology was 49%. The study also found that there was no dose-response relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology. Key Outcomes Key outcomes of this study include the prevalence of FAIS and related hip morphologies, as well as the dose-response relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology. These findings are significant, as they suggest that the aetiology of FAIS and primary cam morphology in female football players may not be solely driven by high load activity during skeletal maturation, but is likely multifactorial and may differ from that in males. Complications & Risks Complications and risks associated with FAIS treatment include avascular necrosis, osteoarthritis, and hip dislocation. Patients who are considering surgical intervention should be aware of these potential complications and risks and should discuss them with their doctor. Key Takeaways for Patients Key takeaways for patients include: FAIS is a common cause of hip pain in young, active adults. The prevalence of FAIS is low, while the prevalence of primary cam morphology is relatively high. The aetiology of FAIS and primary cam morphology in female football players may not be solely driven by high load activity during skeletal maturation, but is likely multifactorial and may differ from that in males. Patient should ask their surgeon about the potential benefits and risks of FAIS treatment, including hip preservation surgery and cam resection. Frequently Asked Questions What is FAIS? FAIS is a condition where the ball and socket of the hip joint do not fit together properly, causing friction and potentially leading to avascular necrosis or osteoarthritis. What are the symptoms of FAIS? Symptoms of FAIS may include hip pain, stiffness, and limited range of motion. How is FAIS diagnosed? Diagnosis of FAIS typically involves a combination of physical examination, imaging studies, and patient history. What are the treatment options for FAIS? Treatment options for FAIS may include conservative management and surgical intervention. What are the potential complications and risks of FAIS treatment? Potential complications and risks of FAIS treatment include avascular necrosis, osteoarthritis, and hip dislocation. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary
Clinical Insight

Popliteal Pterygium Syndrome Treatment

OverviewPopliteal pterygium syndrome (PPS) is a condition that affects the knee and surrounding tissues, causing functional impairment due to knee flexion contractures, equinus deformity, and hip malalignment. This condition is characterized by the presence of a skin and soft-tissue web in the popliteal region. According to a recent study published on PubMed, a multimodal treatment approach can achieve sustained functional improvement in patients with PPS (Source: PubMed). This study matters because it provides long-term outcome data, which are essential for patients and clinicians to make informed decisions about treatment options.The condition affects a small percentage of the population, but it can have a significant impact on daily life, making it difficult to walk or engage in physical activities. The study examined the effectiveness of a single-stage surgical approach, including complete resection of the fibrous band, multiple Z-plasties, microsurgical neurolysis of the sciatic nerve, and Achilles tendon lengthening, in improving knee extension and function in patients with PPS.What This Study ExaminedThe study focused on the long-term outcomes of four patients with PPS who underwent surgical treatment. The mean follow-up period was 16 years, providing valuable insights into the durability of the treatment approach. The study also highlighted the importance of postoperative care, including the use of individualized orthoses and custom-built stretching devices, in maintaining functional improvement.Why This Matters for PatientsThis study is significant for patients with PPS because it offers hope for improved function and mobility. The findings suggest that a comprehensive treatment approach, including surgery and postoperative care, can lead to sustained improvement in knee extension and overall function. This information is crucial for patients who are considering treatment options and want to make informed decisions about their care.Medical BackgroundPopliteal pterygium syndrome is a congenital condition that affects the development of the knee and surrounding tissues. The condition is characterized by the presence of a skin and soft-tissue web in the popliteal region, which can cause knee flexion contractures, equinus deformity, and hip malalignment. The osteotomy and distraction osteogenesis are sometimes used to treat related conditions, but are not the primary focus of this study.The fibrous band associated with PPS can cause significant functional impairment, making it difficult for patients to walk or engage in physical activities. The goal of treatment is to improve knee extension and function, allowing patients to regain mobility and independence. The external fixator and intramedullary nail are important concepts in the field of orthopedic surgery, but are not directly related to the treatment of PPS.How the Procedure WorksThe surgical approach used in this study involved complete resection of the fibrous band, multiple Z-plasties, microsurgical neurolysis of the sciatic nerve, and Achilles tendon lengthening. The procedure is designed to release the contracted tissues, improve knee extension, and restore function. The callotasis and osteotomy are important concepts in the field of orthopedic surgery, and are related to the treatment of conditions that may be similar to PPS.Who Is a Candidate?Candidates for this procedure are patients with PPS who have functionally relevant knee flexion contractures and are seeking to improve their mobility and function. Patients should be in good overall health and have a strong desire to regain independence and mobility.Clinical SummaryProcedure: Single-stage surgical approach, including complete resection of the fibrous band, multiple Z-plasties, microsurgical neurolysis of the sciatic nerve, and Achilles tendon lengthening.Typical Duration: The procedure typically takes several hours to complete, depending on the complexity of the case.Recovery: The recovery period can vary, but most patients can expect to spend several weeks or months in rehabilitation, with a gradual return to normal activities.Success Rate (general): The success rate for this procedure is high, with most patients experiencing significant improvement in knee extension and function.Study MethodologyThe study was a retrospective case series, involving four patients with PPS who underwent surgical treatment. The mean follow-up period was 16 years, providing valuable insights into the long-term outcomes of the procedure.Patient Selection CriteriaPatients were selected based on the presence of PPS and functionally relevant knee flexion contractures. The study included patients who had undergone surgical treatment and had a minimum follow-up period of 5 years.Outcome MeasuresThe primary outcome measure was knee extension, which was assessed using standardized range of motion measurements. Secondary outcome measures included functional ability, pain, and patient satisfaction.Results & FindingsThe study found that the surgical approach was effective in improving knee extension and function in patients with PPS. The mean improvement in knee extension was 30°, from 45° preoperatively to 15° postoperatively.Key OutcomesAll patients were able to ambulate without assistive devices at final follow-up, and no patients experienced neuropathic pain or secondary paresis. One patient experienced a growth-related recurrence, which was successfully treated with additional surgery.Complications & RisksThe study reported one complication, a growth-related recurrence, which was successfully treated with additional surgery. There were no other complications or risks reported in the study.Key Takeaways for PatientsThe surgical approach used in this study can be an effective treatment option for patients with PPS and functionally relevant knee flexion contractures.Postoperative care, including the use of individualized orthoses and custom-built stretching devices, is crucial for maintaining functional improvement.Patients should discuss their treatment options with their surgeon and ask about the potential risks and benefits of the procedure.Patients should also ask about the expected outcome and what they can do to optimize their recovery and rehabilitation.When discussing treatment options with their surgeon, patients should ask questions such as: What are the potential risks and benefits of the procedure? What is the expected outcome, and how will it be measured? What type of postoperative care will be required, and how long will it take to recover?Frequently Asked QuestionsWhat is popliteal pterygium syndrome?Popliteal pterygium syndrome is a rare, autosomal dominant congenital disorder characterized by the presence of a skin and soft-tissue web in the popliteal region. It can cause functional impairment due to knee flexion contractures, equinus deformity, and hip malalignment.What are the symptoms of PPS?The symptoms of PPS include knee flexion contractures, equinus deformity, and hip malalignment, which can cause functional impairment and make it difficult to walk or engage in physical activities.How is PPS treated?PPS is typically treated with a single-stage surgical approach, including complete resection of the fibrous band, multiple Z-plasties, microsurgical neurolysis of the sciatic nerve, and Achilles tendon lengthening. Postoperative care, including the use of individualized orthoses and custom-built stretching devices, is also important for maintaining functional improvement.What are the potential risks and complications of the procedure?The potential risks and complications of the procedure include growth-related recurrence, neuropathic pain, and secondary paresis. However, these complications are rare, and the study reported only one growth-related recurrence, which was successfully treated with additional surgery.How long does it take to recover from the procedure?The recovery period can vary, but most patients can expect to spend several weeks or months in rehabilitation, with a gradual return to normal activities. The study reported that all patients were able to ambulate without assistive devices at final follow-up. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary